"Benzoquinones" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Benzene rings which contain two ketone moieties in any position. They can be substituted in any position except at the ketone groups.
| Descriptor ID |
D016227
|
| MeSH Number(s) |
D02.806.250
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Benzoquinones".
Below are MeSH descriptors whose meaning is more specific than "Benzoquinones".
This graph shows the total number of publications written about "Benzoquinones" by people in this website by year, and whether "Benzoquinones" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2000 | 0 | 2 | 2 |
| 2003 | 0 | 1 | 1 |
| 2007 | 1 | 0 | 1 |
| 2010 | 0 | 1 | 1 |
| 2012 | 2 | 0 | 2 |
| 2014 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Benzoquinones" by people in Profiles.
-
Song N, Zhang MT, Binstead RA, Fang Z, Meyer TJ. Multiple pathways in the oxidation of a NADH analogue. Inorg Chem. 2014 Apr 21; 53(8):4100-5.
-
Song N, Gagliardi CJ, Binstead RA, Zhang MT, Thorp H, Meyer TJ. Role of proton-coupled electron transfer in the redox interconversion between benzoquinone and hydroquinone. J Am Chem Soc. 2012 Nov 14; 134(45):18538-41.
-
Judson PL, Al Sawah E, Marchion DC, Xiong Y, Bicaku E, Bou Zgheib N, Chon HS, Stickles XB, Hakam A, Wenham RM, Apte SM, Gonzalez-Bosquet J, Chen DT, Lancaster JM. Characterizing the efficacy of fermented wheat germ extract against ovarian cancer and defining the genomic basis of its activity. Int J Gynecol Cancer. 2012 Jul; 22(6):960-7.
-
Kang BH, Siegelin MD, Plescia J, Raskett CM, Garlick DS, Dohi T, Lian JB, Stein GS, Languino LR, Altieri DC. Preclinical characterization of mitochondria-targeted small molecule hsp90 inhibitors, gamitrinibs, in advanced prostate cancer. Clin Cancer Res. 2010 Oct 01; 16(19):4779-88.
-
Solit DB, Ivy SP, Kopil C, Sikorski R, Morris MJ, Slovin SF, Kelly WK, DeLaCruz A, Curley T, Heller G, Larson S, Schwartz L, Egorin MJ, Rosen N, Scher HI. Phase I trial of 17-allylamino-17-demethoxygeldanamycin in patients with advanced cancer. Clin Cancer Res. 2007 Mar 15; 13(6):1775-82.
-
Luo J, Benovic JL. G protein-coupled receptor kinase interaction with Hsp90 mediates kinase maturation. J Biol Chem. 2003 Dec 19; 278(51):50908-14.
-
Joseph P, Long DJ, Klein-Szanto AJ, Jaiswal AK. Role of NAD(P)H:quinone oxidoreductase 1 (DT diaphorase) in protection against quinone toxicity. Biochem Pharmacol. 2000 Jul 15; 60(2):207-14.
-
White MK, Strayer DS. Surfactant protein A regulates pulmonary surfactant secretion via activation of phosphatidylinositol 3-kinase in type II alveolar cells. Exp Cell Res. 2000 Feb 25; 255(1):67-76.
-
Harman AW, Kyle ME, Serroni A, Farber JL. The killing of cultured hepatocytes by N-acetyl-p-benzoquinone imine (NAPQI) as a model of the cytotoxicity of acetaminophen. Biochem Pharmacol. 1991 Apr 15; 41(8):1111-7.
-
Bjornsson TD, Schold SC, Friedman HS, Schneider D, Falletta JM. Pharmacokinetics of diaziquone after three different dosage regimens. Cancer Treat Rep. 1985 Dec; 69(12):1383-5.